<SEC-DOCUMENT>0001213900-24-107664.txt : 20241211
<SEC-HEADER>0001213900-24-107664.hdr.sgml : 20241211
<ACCEPTANCE-DATETIME>20241211090017
ACCESSION NUMBER:		0001213900-24-107664
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20241211
DATE AS OF CHANGE:		20241211

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nano Labs Ltd
		CENTRAL INDEX KEY:			0001872302
		STANDARD INDUSTRIAL CLASSIFICATION:	SEMICONDUCTORS & RELATED DEVICES [3674]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-278977
		FILM NUMBER:		241540289

	BUSINESS ADDRESS:	
		STREET 1:		30 FLOOR, DICARA SILVER CENTER
		STREET 2:		NO.29 JIEFANG EAST RD, JIANGGAN DISTRICT
		CITY:			HANGZHOU
		STATE:			F4
		ZIP:			310000
		BUSINESS PHONE:		8615968976786

	MAIL ADDRESS:	
		STREET 1:		30 FLOOR, DICARA SILVER CENTER
		STREET 2:		NO.29 JIEFANG EAST RD, JIANGGAN DISTRICT
		CITY:			HANGZHOU
		STATE:			F4
		ZIP:			310000
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>ea0224400-424b3_nanolabs.htm
<DESCRIPTION>PROSPECTUS SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROSPECTUS SUPPLEMENT NO. 3</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: right; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filed Pursuant to Rule 424(b)(3)</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(to prospectus dated October 1, 2024)</B></FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration No. 333-278977</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Nano Labs Ltd</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>6,521,737 Class A Ordinary Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Prospectus Supplement No. 3 is being filed
to update and supplement the information contained in the prospectus dated October 1, 2024 (as supplemented from time to time, the &ldquo;Prospectus&rdquo;)
that forms a part of our Registration Statement on Form F-1, as amended and supplemented (File No. 333-278977) (the &ldquo;Registration
Statement&rdquo;) with the information contained in three Current Reports on Form 6-K, each filed with the Securities and Exchange Commission
(&ldquo;SEC&rdquo;) on December 9, 2024, December 10, 2024 and December 11, 2024, respectively. Accordingly, we have attached these three
Current Reports to this Prospectus Supplement No. 3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Prospectus and this Prospectus Supplement
No. 3 relate to the proposed resale or other disposition of 6,521,737 Class&nbsp;A ordinary shares issuable upon the exercise of warrants,
or the Warrants, by the selling shareholders identified in the Prospectus. The selling shareholders acquired the Warrants from us pursuant
to certain securities purchase agreement, dated as of April&nbsp;11, 2024, by and among us and the purchasers named therein, or the Securities
Purchase Agreement, in a private placement offering, or the Private Placement. We are not selling any Class&nbsp;A ordinary shares under
the Prospectus and will not receive any of the proceeds from the sale or other disposition of Class&nbsp;A ordinary shares by the selling
shareholders. However, we will receive proceeds from the exercise, if ever exercised, of the Warrants. The selling shareholders or their
pledgees, assignees or successors-in-interest&nbsp;may offer and sell or otherwise dispose of the ordinary shares described in the Prospectus
from time to time through public or private transactions at prevailing market prices, at prices related to prevailing market prices or
at privately negotiated prices. The selling shareholders will bear all commissions and discounts, if any, attributable to the sales of
Class&nbsp;A ordinary shares. We will bear all other costs, expenses and fees in connection with the registration of the shares. See &ldquo;Plan
of Distribution&rdquo; beginning on page 132 of the Prospectus for more information about how the selling shareholders may sell or dispose
of their Class&nbsp;A ordinary shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is no assurance that the holders of the
Warrants will elect to exercise any or all of such Warrants or that they will exercise any or all of them for cash. The likelihood that
warrant holders will exercise the Warrants and any cash proceeds that we would receive is dependent upon the market price of our Class
A ordinary shares. If the market price of our Class A ordinary shares is less than the exercise price of the Warrants, meaning the Warrants
are &ldquo;out of the money,&rdquo; we believe the holders of the Warrants will be unlikely to exercise their Warrants, and we are unlikely
to receive proceeds from the exercise of Warrants. The amount of cash we would receive from the exercise of the Warrants will decrease
to the extent that Warrants are exercised on a cashless basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Prospectus Supplement No. 3 updates and supplements
the information in the Prospectus and is not complete without, and may not be delivered or utilized except in combination with, the Prospectus,
including any amendments or supplements thereto. This Prospectus Supplement No. 3 should be read in conjunction with the Prospectus and
if there is any inconsistency between the information in the Prospectus and this Prospectus Supplement No. 3, you should rely on the information
in this Prospectus Supplement No. 3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Class&nbsp;A ordinary shares are listed on
the NASDAQ Capital&nbsp;Market under the symbol &ldquo;NA.&rdquo; The closing price for our Class&nbsp;A ordinary shares on December 10,
2024 was US$8.13 per Class&nbsp;A ordinary share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Investing in our securities involves a high
degree of risk. See &ldquo;Risk Factors&rdquo; beginning on page 13 of the Prospectus and other risk factors contained in the documents
incorporated by reference herein for a discussion of information that should be considered in connection with an investment in our securities.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Neither the U.S. Securities and Exchange Commission
nor any other regulatory body has approved or disapproved of these securities or determined if this prospectus is truthful or complete.
Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>The date of this prospectus supplement is December
11, 2024.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>WASHINGTON, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FORM 6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>REPORT OF FOREIGN PRIVATE ISSUER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PURSUANT TO RULE 13a-16 OR 15d-16 UNDER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">For the month of
December 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Commission File Number: 001-41426</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Nano Labs Ltd</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact name of registrant as specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">China Yuangu Hanggang Technology Building</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">509 Qianjiang Road, Shangcheng District,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Hangzhou, Zhejiang, 310000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">People&rsquo;s Republic of China</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Address of principal executive offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Form 20-F &#9746; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form
40-F &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXPLANATORY NOTE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">The document attached as exhibit 99.1 to this Form
6-K is hereby incorporated by reference into the Registrant&rsquo;s Registration Statement on <A HREF="https://www.sec.gov/Archives/edgar/data/1872302/000119312523212289/d466253df3.htm">Form F-3</A> initially filed with the U.S. Securities
and Exchange Commission on August 14, 2023 (Registration No. 333-273968) and shall be a part thereof from the date on which this current
report is furnished, to the extent not superseded by documents or reports subsequently filed or furnished.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-indent: 30.05pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nano Labs Ltd</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: December 9, 2024</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Jianping Kong</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jianping Kong</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman and Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-indent: 30.05pt">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="border-bottom: black 1.5pt solid; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit No.</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit 99.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="#A_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>
<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="A_001"></A>Nano Labs Announces Pricing of Unregistered
Sale of Equity Securities&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hong Kong, December 9, 2024 /PRNewswire/ -- Nano
Labs Ltd (Nasdaq: NA) (&ldquo;we,&rdquo; the &ldquo;Company&rdquo; or &ldquo;Nano Labs&rdquo;), a leading fabless integrated circuit design
company and product solution provider in China, today announced that it entered into a share subscription agreement (the &ldquo;Subscription
Agreement&rdquo;) with certain investors (the &ldquo;Investors&rdquo;) on December 9, 2024 to sell 5,611,459 Class A ordinary shares of
the Company in a private placement. The purchase price per Class A ordinary shares is US$6.46, being the average closing price of the
previous 60 trading days prior to the signing of the Subscription Agreement, and the aggregate purchase price of the Private Placement
is approximately US$36.25 million (the &ldquo;Aggregate Purchase Price&rdquo;). The Aggregate Purchase Price will be satisfied in U.S.
dollars, Bitcoin and USDT. The shares are offered in a transaction not required to be registered under Section 5 of the Securities Act.
The closing may take place on a non-contemporaneous basis in 10 business days, subject to customary closing conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release shall not constitute an offer
to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities
in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under
the securities laws of any such state or jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Nano Labs Ltd</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nano Labs Ltd is a leading fabless integrated
circuit (&ldquo;IC&rdquo;) design company and product solution provider in China. Nano Labs is committed to the development of high throughput
computing (&ldquo;HTC&rdquo;) chips, high performance computing (&ldquo;HPC&rdquo;) chips, distributed computing and storage solutions,
smart network interface cards (&ldquo;NICs&rdquo;) vision computing chips and distributed rendering. Nano Labs has built a comprehensive
flow processing unit (&ldquo;FPU&rdquo;) architecture which offers solution that integrates the features of both HTC and HPC. Nano Lab&rsquo;s
Cuckoo series are one of the first near-memory HTC chips available in the market*. For more information, please visit the Company&rsquo;s
website at: https://ir.nano.cn/.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">*</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">According to an industry report prepared by Frost &amp; Sullivan.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Forward-Looking Statements</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>This press release contains forward-looking
statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities
Litigation Reform Act of 1995. These forward-looking statements include, without limitation, the Company&rsquo;s plan to appeal the Staff&rsquo;s
determination, which can be identified by terminology such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;expect,&rdquo; &ldquo;anticipate,&rdquo;
&ldquo;aim,&rdquo; &ldquo;estimate,&rdquo; &ldquo;intend,&rdquo; &ldquo;plan,&rdquo; &ldquo;believe,&rdquo; &ldquo;potential,&rdquo; &ldquo;continue,&rdquo;
&ldquo;is/are likely to&rdquo; or other similar expressions. Such statements are based upon management&rsquo;s current expectations and
current market and operating conditions, and relate to events that involve known or unknown risks, uncertainties and other factors, all
of which are difficult to predict and many of which are beyond the Company&rsquo;s control, which may cause the Company&rsquo;s actual
results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding
these and other risks, uncertainties or factors is included in the Company&rsquo;s filings with the Securities and Exchange Commission.
The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or
otherwise, except as required under law.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>For investor inquiries, please contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Nano Labs Ltd</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ir@nano.cn</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Ascent Investor Relations LLC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Tina Xiao</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Phone: +1-646-932-7242</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email: investors@ascent-ir.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>WASHINGTON, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FORM 6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>REPORT OF FOREIGN PRIVATE ISSUER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PURSUANT TO RULE 13a-16 OR 15d-16 UNDER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">For the month of
December 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Commission File Number: 001-41426</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Nano Labs Ltd</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact name of registrant as specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">China Yuangu Hanggang Technology Building</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">509 Qianjiang Road, Shangcheng District,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Hangzhou, Zhejiang, 310000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">People&rsquo;s Republic of China</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Address of principal executive offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Form 20-F &#9746; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form
40-F &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXPLANATORY NOTE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">The document attached as exhibit 99.1 to this Form
6-K is hereby incorporated by reference into the Registrant&rsquo;s Registration Statement on <A HREF="https://www.sec.gov/Archives/edgar/data/1872302/000119312523212289/d466253df3.htm">Form F-3</A> initially filed with the U.S. Securities
and Exchange Commission on August 14, 2023 (Registration No. 333-273968) and shall be a part thereof from the date on which this current
report is furnished, to the extent not superseded by documents or reports subsequently filed or furnished.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Options: NewSection; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-indent: 30.05pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nano Labs Ltd</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: December 10, 2024</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Jianping Kong</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jianping Kong</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman and Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-indent: 30.05pt">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="border-bottom: black 1.5pt solid; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit No.</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit 99.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="#A_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="A_002"></A>Nano Labs Announces $5.5 Million BTC Purchased
as of December 10, 2024</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hong Kong, December 10, 2024 /PRNewswire/ -- Nano
Labs Ltd (Nasdaq: NA) (&ldquo;we,&rdquo; the &ldquo;Company&rdquo; or &ldquo;Nano Labs&rdquo;), a leading fabless integrated circuit design
company and product solution provider in China, today announced that it has invested in Bitcoins (&ldquo;BTC&rdquo;) through Hashkey,
a licensed virtual asset trading platform in Hong Kong. As of December 10, 2024, the Company owns approximately 55.6 Bitcoins, valued
at about 5.5 million US dollars. at an average price of approximately $99,400 per BTC, inclusive of transaction fees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This strategic investment reflects the Company&rsquo;s
commitment to diversifying its asset allocation while exploring potential application of blockchain technology in high-performance computing
and distributed storage solutions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A group of investors, including FENBUSHI US, Longling
Capital, Golden Forest, and others, recently entered into a share subscription agreement with Nano Labs. The Company will continue to
monitor developments in the BTC market closely and adjust its investment scale and strategy as appropriate in response to market conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Nano Labs Ltd</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nano Labs Ltd is a leading fabless integrated
circuit (&ldquo;IC&rdquo;) design company and product solution provider in China. Nano Labs is committed to the development of high throughput
computing (&ldquo;HTC&rdquo;) chips, high performance computing (&ldquo;HPC&rdquo;) chips, distributed computing and storage solutions,
smart network interface cards (&ldquo;NICs&rdquo;) vision computing chips and distributed rendering. Nano Labs has built a comprehensive
flow processing unit (&ldquo;FPU&rdquo;) architecture which offers solution that integrates the features of both HTC and HPC. Nano Lab&rsquo;s
Cuckoo series are one of the first near-memory HTC chips available in the market*. For more information, please visit the Company&rsquo;s
website at: ir.nano.cn.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left">*</TD><TD STYLE="text-align: justify">According to an industry report prepared by Frost &amp; Sullivan.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Forward-Looking Statements</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>This press release contains forward-looking
statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities
Litigation Reform Act of 1995. These forward-looking statements include, without limitation, the Company&rsquo;s plan to appeal the Staff&rsquo;s
determination, which can be identified by terminology such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;expect,&rdquo; &ldquo;anticipate,&rdquo;
&ldquo;aim,&rdquo; &ldquo;estimate,&rdquo; &ldquo;intend,&rdquo; &ldquo;plan,&rdquo; &ldquo;believe,&rdquo; &ldquo;potential,&rdquo; &ldquo;continue,&rdquo;
&ldquo;is/are likely to&rdquo; or other similar expressions. Such statements are based upon management&rsquo;s current expectations and
current market and operating conditions, and relate to events that involve known or unknown risks, uncertainties and other factors, all
of which are difficult to predict and many of which are beyond the Company&rsquo;s control, which may cause the Company&rsquo;s actual
results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding
these and other risks, uncertainties or factors is included in the Company&rsquo;s filings with the Securities and Exchange Commission.
The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or
otherwise, except as required under law.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>For investor inquiries, please contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Nano Labs Ltd</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ir@nano.cn</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Ascent Investor Relations LLC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Tina Xiao</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Phone: +1-646-932-7242</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email: investors@ascent-ir.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>WASHINGTON, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FORM 6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>REPORT OF FOREIGN PRIVATE ISSUER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PURSUANT TO RULE 13a-16 OR 15d-16 UNDER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">For the month of
December 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Commission File Number: 001-41426</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Nano Labs Ltd</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact name of registrant as specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">China Yuangu Hanggang Technology Building</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">509 Qianjiang Road, Shangcheng District,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Hangzhou, Zhejiang, 310000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">People&rsquo;s Republic of China</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Address of principal executive offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Form 20-F &#9746; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form
40-F &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXPLANATORY NOTE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">The document attached as exhibit 99.1 to this Form
6-K is hereby incorporated by reference into the Registrant&rsquo;s Registration Statement on <A HREF="https://www.sec.gov/Archives/edgar/data/1872302/000119312523212289/d466253df3.htm">Form F-3</A> initially filed with the U.S. Securities
and Exchange Commission on August 14, 2023 (Registration No. 333-273968) and shall be a part thereof from the date on which this current
report is furnished, to the extent not superseded by documents or reports subsequently filed or furnished.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Options: NewSection; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-indent: 30.05pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nano Labs Ltd</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: December 11, 2024</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Jianping Kong</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jianping Kong</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman and Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-indent: 30.05pt">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="border-bottom: black 1.5pt solid; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit No.</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit 99.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="#A_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="A_003"></A>Nano Labs Announces Closing of US$36.25 Million
Private Placement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hong Kong, December 11, 2024 /PRNewswire/ -- Nano
Labs Ltd (Nasdaq: NA) (&ldquo;we,&rdquo; the &ldquo;Company&rdquo; or &ldquo;Nano Labs&rdquo;), a leading fabless integrated circuit design
company and product solution provider in China, today announced the closing of its previously announced private placement of 5,611,459
Class A ordinary shares at a purchase price of US$6.46 per share, for aggregate gross proceeds of approximately US$36.25 million. As previously
disclosed, the aggregate purchase price was satisfied in U.S. dollars, Bitcoin and USDT. The shares were offered in a transaction not
required to be registered under Section 5 of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release shall not constitute an offer
to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities
in any state or jurisdiction in which such offer, solicitation<FONT STYLE="font-family: Times New Roman, Times, Serif">,</FONT> or sale
would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Nano Labs Ltd</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nano Labs Ltd is a leading fabless integrated
circuit (&quot;IC&quot;) design company and product solution provider in China. Nano Labs is committed to the development of high throughput
computing (&quot;HTC&quot;) chips, high performance computing (&quot;HPC&quot;) chips, distributed computing and storage solutions, smart
network interface cards (&quot;NICs&quot;) vision computing chips and distributed rendering. Nano Labs has built a comprehensive flow
processing unit (&quot;FPU&quot;) architecture which offers solution that integrates the features of both HTC and HPC. Nano Lab's Cuckoo
series are one of the first near-memory HTC chips available in the market*. For more information, please visit the Company's website at:
ir.nano.cn.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left">*</TD><TD STYLE="text-align: justify">According to an industry report prepared by Frost &amp; Sullivan.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Forward-Looking Statements</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>This press release contains forward-looking
statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, </I>and <I>as defined in the U.S. Private
Securities Litigation Reform Act of 1995. These forward-looking statements include, without limitation, the Company&rsquo;s plan to appeal
the Staff&rsquo;s determination, which can be identified by terminology such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;expect,&rdquo;
&ldquo;anticipate,&rdquo; &ldquo;aim,&rdquo; &ldquo;estimate,&rdquo; &ldquo;intend,&rdquo; &ldquo;plan,&rdquo; &ldquo;believe,&rdquo;
&ldquo;potential,&rdquo; &ldquo;continue,&rdquo; &ldquo;is/are likely to&rdquo; or other similar expressions. Such statements are based
upon management&rsquo;s current expectations and current market and operating conditions, and relate to events that involve known or unknown
risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company&rsquo;s control,
which may cause the Company&rsquo;s actual results, performance or achievements to differ materially from those in the forward-looking
statements. Further information regarding these and other risks, uncertainties or factors is included in the Company&rsquo;s filings with
the Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement as a result
of new information, future events or otherwise, except as required under law.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>For investor inquiries, please contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Nano Labs Ltd</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ir@nano.cn</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Ascent Investor Relations LLC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Tina Xiao</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Phone: +1-646-932-7242</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email: investors@ascent-ir.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !I D # 2(  A$! Q$!_\0
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MDW#><\0XNV3PE-6L]'RKIK)^[\E=];)6;W6'OLOP_P#M?Z_$_K4\_P!OT_\
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MX9W7Q8^(^@6NFWOCNY'B1?#OACPH-<8[-'.5_P")]XB("N%3:4)P2<5]S?\
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M^)MOJ>M?:+W3?#7A#P3X<=_^$D\=>*-;R(]$T/.W.1R?$>"B'.X_<,GY@?\
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M/[X!]4Q?9V^>WW=C^RD$-D=?7_/%05_'MX<_X.:?BI%J@/C+]E'P%<Z/@_\
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M-;T;D'(&X]C7]"Y;BH\%>%ZQ^#48YU5DG%N*NW5:Y=&KM\KCI=ZJSTO;T?\
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MIXES; *RR7DFXJS37++D3W2UNK144TM]6TNC#XC=6371_>NOS>B[^3/Z<_\
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MZ+D^]?%'_!S=X/F,7[(/C@08M[:\^,?AJ^N^I#$> ==T($>H"ZYGT[BO:/\
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M)Q2M))I6E)>\FMM5?5VLGI8>&^J7?\WZ^70^\O\ @VN\53Z;^V'\9_"L\_\
MH_B?]GP7OV3H1JFA>-?#XSSTP#KA'7TZ5_:P9H8H?/F.,]\9QSZ_AW]>_4?P
M'?\ !!KQ5<>&_P#@I7\)[$S_ &;3_&/@3XG^&+S_ *?P/!8U_0C_ .4+^7!-
M?V*_\%!_C7#^SM^Q=^T?\5/.^R:CI?PZU?1_#I'\7B?QO_Q3WA_GN6\1:VA]
M@,=J_,/$[+WB>/5@\+&3_MJ5#H]7.:A*VFEM;]DM3S\4O]K^?X?\,?P%_MT?
M&K_AHC]L']H;XP03_:='\3?%/Q.OAO\ TS_F5]! T#0>.G_(N:%G' XQTQ7]
M?W_! /X*?\*Q_8*T?QQ?V*VVK_'CQYXG^((+8/V[PT6&@: ,''/_  CVB CG
M.X#H2*_ABT;1]5\2:IH_AS2L7&L:[K&EZ+9_9.,ZIKNM?V#_ /7%?Z?G[/7P
MRTKX'?!#X4_"72HK:UT_X=>!/"WA@6MKM.-3T/10NMX(^\&(W#/.6V^U?3^*
M^(64\-Y-PQ@W:T8N2TU4813OY7ZM:OKWWQ.UO+]&?+W_  53^&/_  M3_@GO
M^U/X6MXE-_IWPVU3QI:'C-J_@75D\>*XQP/DT!LJ.PR!Q7^<I!>3Z=]GU6#F
MXTO^R[ZS[YU30O\ B?=<G_/7UK_5*\;^&++QKX.\9>#M4A$^G>,?#?B3PU>V
MV 2=,US26T64$<#YU8@'G&_(Z"O\M7QAX;U3P3XM\4>#M5Q;:AX-\2>*/#&L
M>O\ :FA:U_8/^?RQBN?P7Q3G@\YR]O5P=E>[?-&<7I>^]^GZAAMO+_@+^MC_
M $ZOV=O'D/Q2^!WP9^)$$J73^,_A;X#\275W_?U+6M"T.360?0A]XSTSD]>!
M^-7_  <3_&O_ (0/]C3PO\);&]N+76/CO\4],T2ZV]#X6\$$>(-?)R,#YAH9
MST.03SG/U#_P11^( ^(7_!-S]G_/_'QX#M?$WPRO>G+>!-<UW0%S^('X'CI7
M\[__  </_&O_ (6#^VCX7^$EE?V]SI'P(^%FF6=Y:6V"1XH\=DZ_KH_X#X;_
M +# '8 9SCGY'A/)'B_$?ZDXW62UZLYWO9)5)RC=6L[N<;72V>CL8X:SQ:[<
MS]-U\O,_.?\ X)N? YOVB?VY/V</AG>V(U/0+GXCZ9XH\769.T'PSX%'_">:
MX,]LG0\#(/KS7[4?\'*WQFGO/'?[.'[/=C+MT_0_#?B?XN>)+3_F&ZAJFN:P
MN@:$&'7</[#UL9R<#7N/;G_^#:GX)G7OC1\>/VA;VP#:?\.?".D?#'PW=$X
M\3^.777M?;MROAK0]#<=\ZZ,G/!^+_\ @OAXBGUS_@I#\1]*FF$^G^#OAO\
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MJ+?/&48I<UG>3DDE9ZM>=O1P_P#LN$?=[[M_Y]==^A_<+\)O ]M\.?AI\/?
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M]H'A;2OM-SX@\4:QI?AG1S:#_F*:[K7]@_C_ )ZFO]0#X ?#+2O@;\%?A/\
M![1H;6WTWX=>!/"_@W9:@?V>K:'I")JVT= '=78%P#N91P%8#^"W_@C5\%(/
MCC_P4,^!%A>P&YT#X=7FJ?&?5_M>#SX&S_877_J8SHG\_6O]$A<[L>BX_EFO
MT#QIS)K-LIR5.T:5--I72C=**MT6D7I97O<ZLRZ6Z*_W-+IZ_<6Z**,CIGGT
MK\B/.&%E&>^3G'TX'TZ?7OBOG/X_?'CP1^SA\)_&OQI^)E]:Z=X1\":/JNLW
MI5E.HWK*'&B:/HX)1FU[Q0^$ 7<P=QN1<%U^AR<<FOX7?^"W_P#P4 '[1WQ:
M_P"&;_A;J?VCX1_!7Q%J/_"37=L%_L[XD_$U=QUK5692V?#OA LQ/SLN]W93
MM; ][A'AS%<3YO'!I6A%J4Y;1A3B[MM[<TK65VK:O[)OATG9]++SVMY=C\J?
MVL_VF_'W[7WQW\;_ !N\>S8U;Q->8T;P\;TMIOA+POH1SH?@S1&/)+'EF.2S
M')))S7JO[#'[</B']A+QYXO^)G@CX2?#CXD>+_$WAU?#5EJOC<ZSIFI^$M,1
M@VM_V)_PC_;Q6P#<'G !^4D5ZO\ \$V_^"8OC_\ ;_UGQ=JO_"4-\,?@_P"!
M;T:)XD^(*Z.-2U/7/$Q.&\'>"-$9E4)&,LQ+9(&%#R%$;]NO^(9+P#V_:N\<
M$^G_  K?P7S_ ./5_0V<<1\"91@?]5\8_=C&,*BIWM=1A=/V=D]KVNW:UU[U
MI=/UGI?3;R[=_P SY'/_  <N_M0G_FWKX)_^#KQE_4U^&'[1WQX\4_M-?''X
MG?'3QAI6C:+XG^)OB)-7U?2M!=GT^P"Z)H&@C1M%=V9W8^'-#R79BS'+,2Q)
M/]. _P"#9?X?XY_:M\?@^G_"M]$-?A/_ ,%)/V$+C]@7X[Z-\)H?'MU\1= \
M4^!-,\9^&]?O='33M4&-:_L#^QM=*,Z\CYAAC@8! ;*C#A#,?#E9LL)PU&V<
M22UM*-TK2:M));W>JOZG1AGA/G^NFW3\3]CO^#8S7_(\<_M;>%/.W?VKX;^&
M'B8# )SH6M>/M#ZD=/\ B=]/Z5_6+XA\2Z7X:T/5_$>J2P0:/H.DZCJ^KW5P
MVT6.F:/I/]M.[#H?*3YSG(QTRP7'\57_  ;D>(QI'[;OQ$T6XG&?$_[/VIV2
MVG<'0_&>@ZX>WH?RK^B'_@L?\=S\"/\ @GO\;]0L[D0:_P#$2ST_X,^&_?4_
M'9.A:T._W?#?]M\\\K^%?E_'N73Q/B.\$HW>=5*%K)^ZI2BIR>GV>64M;-J*
M[I'!B4GB_G^NW8_@Z_:%^+.J?'?X\?&#XT:I/<B?XG_$?Q1XR N^!I^E:YK6
M-"''_4N?V'X7YY_IQW@GXD>/_AO?W.J_#GX@>-O!-_=9LKV[\$>)-9\-_;\_
M]B_^&>/QSR>V_9Q^#>J?M _'OX,_!'1#<"?XB>._#'@PD\#3]+&M9U[6R?3_
M (1S&<]._-?Z1OA#]E;]G/P1X2\/>#=$^!_PFMO#WAC1],T72+7_ (5WX/O\
M:9HN%4<>'LY.< CHQ#+A\ _I_%?&>!X(IY3DCRB.>)4XWC+E245&,=FFDEMJ
MDO=LEI8[\1B/JR6ST5_+3YZ_U<_SC/\ AJC]JB7_ (]_VC/CK_X<CQD!_P"I
M)_D?4FL?6/VD/VA?$EA<:)XB^/WQCUO1]4/V*\TG5_B1XR_LR_X_[&/T]Z_T
MP[3X(_!S2A-%I'PL^'.F07.?M1M/ WA#3DYZED3P^JR#'0,2 3ZU\K_M6_L@
M?LH?$CX%?$72?B-\'OACIF@:/X%\3:R==LO!^B>'M3\+:CHFC-K2ZWH^O:*H
M;P^% ,C;&#97[TH(#_'X3Q.R:>-BO]4J<7.48IKV<K.<HQ32]FK\KDFDKMVT
M39S+$IM>?]=]#_/B^ ?@GX6_$?XN^ /!'QF^)ES\'OASXQ\1FS\7?$NTT@>(
MO[#..!G''I_PE7;/KU_T8_V2OV5_@?\ LB_"72/A;\!_#UMIWAD;=9OO$%Y>
M#4_$WBS5& 8^,-<UO<IU]VW(5+$@#;@#<=W^9?%Q8G[1T%H<^O\ GZ5_IA?L
M#GQA+^Q=^RQ_PG,UU<^,/^%#_# ^(OM>/[1.J?\ "&:+QK(!)W;?O@#)&",X
M-='C0L6L)E#AF;C"<%>A%1C"[2FFXQ@G*5FJ=G>*5FES78\2]']^_DS^?'_@
MOS^PQ\6O&7COPQ^UG\)/".M^.M)'A'3_ (?_ !@TKP[8ZUJ/B30ET.24:#XP
M&BC*MH,7]L%)%#%E*Y=5W"OY4IIC9R^?<?:;:>U]<Z:>/7'0\=_SK_6$4#D9
M!'I_CD?Y_*O%O$OP ^!/C@3S>,O@?\)_%C7)/VG_ (2'X=>#_$08@<%O[>\/
M,6'3)<'UV\"OE^&?%+&9#DZR?%97&O235FI7YDGJG[LX[;-6>MFDU<PH8FVF
M]O\ AMGZ/9>G<_RZ_P#A*]6_Z'+6_P#PIM8_QJS#XJUS_EAXJUL?]S)K/^)_
M4^M?Z<O_  QQ^R1_T:Y^SA_X97X;?_,[7E_C7_@GC^Q1\0M&U'1/$?[+7P4_
ML[5 1=C2O 6B^&]2]=YUOP\JMN]MP&,\ X(^IAXT91)J+X2HINT;KDEJ[1YG
M:FK6;O\ Y&_UE:6=_P /S9_ S\%/V[OVR?V=]5TZ_P#A9^T5\1]%L-).1X4U
M;Q'K/B3P/?'!&[6_!'B#_BF0<''!S^=?W<_\$Y/VP(?VUOV7?!'QGFTK3M%\
M8_;-2\&?$C2M)"G2]"\>:!L77!HI+@G0I5;0_$J,Q(VZWR1M^?\ S\?VDO!/
M@[X8?M#_ !O^'/PXUO\ X2/P!X$^*?CKPSX0U7/_ !^Z;H>LY*Y!P<=,@\_7
M&/[*O^#=;P3JOA;]@-_$=]_Q[_$;XU_$WQ/HY.>=+ T'06&>!_R,.B:X#Z9Y
MH\5LLR7_ %;RG.X4XT\WK*,[1IJ#:E!2BIVA!MJ,E'WKN/+RNUN5&)Z]/Z9_
M/5_P7&^!LWP9_P""@?Q/U46/V?P_\;='TOXL^&[O[)G3 =<T7_A'_'8)!.67
MQ+H1!YZZ\>F!7[7?\$V]!^%G_!2O_@E%-^R5\8=5UNVU#X3ZR?AY?7?A^\_L
MWQ-X2_L+6&U[X3^-=#;C:?\ A'< 'YMQT'Q,NT9W+[/_ ,%W?V.K[]HK]ER#
MXR>!]*.H_$_]G6\U3Q*;.UM$.IZ]\,-;./'.D93<<^&(]GBD;G^YX?\ $8"(
M[,*_FI_X),_MQG]B+]JK2/$7B*^N1\&/BA9Z7\/OB_:D9_L_30/^)#XUP<C_
M (I+Q'^?@L>)^E<^'Q6*XK\/,K^IZYYPZ[J,=:B4%S)P3O+6"=K:/5-VN'^\
MX335Z^O^>O\ 6US^N3_@G]_P2D^#'_!/[7O''C'P?XI\6_$CQ_XRL]-T:[\5
M^-;32-/_ +#\,QG*Z)HFC>'PJ1C*\AOO$[01M.?UM&",@8S_ $X%<YIFIV&O
M6&GZII5];:CI^I6HN[.\M<G3KW3FX!!.X'*N,9Z X/&0.D  X%?B^88_&YEC
M'B<=.4YI<KE-^_>*<=K1Y4K-6C%6UO=MG _RT_K5C%3!R3TZ?X_Y_.OFOX\?
MLQ_ K]J+PG_PA'QW^'7A3XCZ#;!;ZSLO$=E_Q,]"U/DC5]#UPL/$.@2<G+HZ
MG(3<611N^E@ .G]:7./_ -1/\JPPTGA/>PC<)7OS1FXN^]^9-/\ '[U<+O>[
M/RR^!O\ P2&_8,^ /BV'QOX)^ >AZCXPTV^_MC1-6\;:MK/Q%?P_J@7/_$B/
MB-G&ADD9!"@8/(X.?U%\CW_7_P"M4P*Y..Y]^_?VY..W\J=71B,7BL=KC*DJ
MK2LN><JFE[_:<K:I/\-4E8NV%%%%8-)JS2M;JEM:W5/H(_/_ /;K_8=^%G[>
MGPFM_A+\0[_6_#MQH7B/3?$WAWQMX4.D?\)+X3U6,MET&N)(-S:"P1U(#$?,
M/]7MD_/'X@?!KX/_ /!%W_@G-^T>?AWXB\2:UXH^(ROHNC>+/%7]DGQ+KOQ.
M\<Z.O@/0CH_]@A K^%E.L>*EC*!HRLH#N,X_H!E< 9)[Y/O_ /7SD8'Z5_"U
M_P %T?V\++]IWX^6_P "?AGJG]H?"']G^\U.SOM5M+P'3/%?Q1P!KNL$KD-X
M>\(X_P"$6)R<G_A)R#M  ^OX#P^;\08ZGP[SR620J1K23?N6A/GM=W2O**M:
M26^CM8Z<-NK:KKIIT_K8_.C_ ()Y? B;]I7]M']GCX2SP?VEH^I?$?3/%'C
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MMZQ_T$]>\4Z[K7]O]/7_ (2/U'_UOMZT_P""6/\ P46U&^_LJ#]D3XPB<?\
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M_P#@_P"97'3\6_F:_E<_X.;?#MQ<>!?V2O&$$ ^SZ3X\^)OA>]NA@E6U[1-
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M& -<8$\@-_/W_P '#/P3USP'^VUIWQBGM[G_ (1?XV_#CPPND:M]CSIB^*/
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M7'!;"_,.=9+X196UC5F_M'%I\OM/:6:U5TG*]VNJULG9L7^QK7M^G_#'XY?
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M%<'D\YP>F,8Z_G22R*N3_/Z?Y[^Y-?%G[2/[=/[+/[*6EW5]\;OC/X1\-:A
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M$GQ-N]7\;_LA^(8/@IXHNF-Y>?#/Q"-8U+X97PQ)AM$.[_A)_ .XQXVQ[_"
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
..**** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
